A new study from Michigan Medicine suggests that many older adults are not prescribed disease-modifying medications for their inflammatory autoimmune disease. A team of researchers analyzed all ambulatory visits for rheumatoid arthritis by adults 65 years of age and older, representing 7.8 million visits from 2005 to 2016. Jiha Lee, M.D, M.H.S, lead author of the paper and a rheumatologist at U-M Health, shares insights on discusses the importance of early and aggressive treatment of rheumatoid arthritis and how physicians can better target older adults to ensure optimized treatment.
